TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22221277

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention that paired behavioral treatment with naltrexone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 40
Study: 20122373

Group type: EXPERIMENTAL
Intervention: Ziprasidone plus mood stabilizer
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo plus mood stabilizer
Number of subjects: 240
Study: 18499110

Group type: EXPERIMENTAL
Intervention: Melatonin (4 mg prolonged release)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16013623

Group type: EXPERIMENTAL
Intervention: Outpatient ACL reconstruction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inpatient ACL reconstruction
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 12435211

Group type: EXPERIMENTAL
Intervention: Learned Irrelevance (LIRR) pre-exposure trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Latent Inhibition (LI) pre-exposure trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doubling the number of CS pre-exposures in rabbits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Latent Inhibition (LI) in humans
Number of subjects: 0
Study: 10526725

Group type: EXPERIMENTAL
Intervention: 8-mm needles
Number of subjects: 50

Group type: COMPARATOR
Intervention: 12.7-mm needles
Number of subjects: 50
Study: 7747149

Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omnivores
Number of subjects: 0
Study: 2188495

Group type: EXPERIMENTAL
Intervention: Educational program and questionnaire (group I, 25 patients)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Questionnaire only (group II, 22 patients)
Number of subjects: 47
Study: 6108319

Group type: EXPERIMENTAL
Intervention: Ketazolam (once-a-day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Diazepam (three times a day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (once or three times a day)
Number of subjects: 101
Study: 31276189

Group type: EXPERIMENTAL
Intervention: Brodalumab 210 mg every 2 weeks
Number of subjects: 687

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 687

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 687
Study: 28774898

Group type: EXPERIMENTAL
Intervention: trabectedin 1.5 mg/m2 as a 24-hour continuous intravenous infusion once every 3 weeks
Number of subjects: 518

Group type: COMPARATOR
Intervention: dacarbazine 1,000 mg/m2 i.v. once every 3 weeks
Number of subjects: 518
Study: 25774657

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 819
Study: 23996244

Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide-coated bioactive stents (BAS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 28
Study: 21418785

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 25 mg twice weekly
Number of subjects: 549
Study: 19263128

Group type: EXPERIMENTAL
Intervention: Training on a laparoscopic simulator
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training
Number of subjects: 0
Study: 17420365

Group type: EXPERIMENTAL
Intervention: Intracameral or intravitreal injection of 40 microg of gentamicin sulfate and 45 microg of clindamycin
Number of subjects: 346

Group type: COMPARATOR
Intervention: Balanced salt solution
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Intravitreal injection
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Intracameral injection
Number of subjects: 346
Study: 14633177

Group type: EXPERIMENTAL
Intervention: Induction treatment with a daily dose of 5 MU of IFN‐alpha2b for 4 weeks, followed by 5 MU three times a week with ribavirin (1000‐1200 mg/day, according to weight) until completing 1 year of treatment.
Number of subjects: 614

Group type: COMPARATOR
Intervention: Standard dose of IFN‐alpha2b of 3 MU three times per week for 48 weeks together with ribavirin (1000‐1200 mg/day, according to weight).
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Induction treatment in patients with genotype 1 and elevated viral load (>2 x 10(6) copies/ml).
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Induction treatment compared to standard treatment regarding dropouts and side effects.
Number of subjects: 614
Study: 11042297

Group type: EXPERIMENTAL
Intervention: Lidocaine spray
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 9364690

Group type: EXPERIMENTAL
Intervention: DTaP
Number of subjects: 4181

Group type: COMPARATOR
Intervention: DTwP
Number of subjects: 4181
Study: 1550038

Group type: EXPERIMENTAL
Intervention: Breakfast treatment (three meals per day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No-breakfast treatment (two meals per day)
Number of subjects: 52
Study: 3993543

Group type: EXPERIMENTAL
Intervention: Propranolol (160 to 320 mg/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Atenolol (50 to 200 mg/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 39
Study: 31333187

Group type: EXPERIMENTAL
Intervention: Kinesiotherapy (kinesio taping)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham taping (control)
Number of subjects: 50
Study: 29738358

Group type: EXPERIMENTAL
Intervention: High blood pressure group
Number of subjects: 420

Group type: COMPARATOR
Intervention: Normal blood pressure group
Number of subjects: 420
Study: 27282119

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MInt) adherence education (EdMInt) delivered in four sessions
Number of subjects: 336

Group type: COMPARATOR
Intervention: Education control (EC) delivered at 3-month intervals
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MInt) adherence education (EdMInt)
Number of subjects: 336
Study: 25316430

Group type: EXPERIMENTAL
Intervention: Polyherbal formulation (500 mg, twice daily)
Number of subjects: 232
Study: 23177225

Group type: EXPERIMENTAL
Intervention: Electrical stimulation to the wrist and finger extensor muscles for 1 hour a day over 4 weeks, with splinting for 12 hours a day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Splinting alone for 12 hours a day over 4 weeks
Number of subjects: 36
Study: 20140099

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal Sleep (RW)
Number of subjects: 23
Study: 18839845

Group type: EXPERIMENTAL
Intervention: Kongsap manual phacofragmentation (Group 1)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Phacoemulsification (Group 2)
Number of subjects: 102
Study: 15784709

Group type: EXPERIMENTAL
Intervention: GH by sc injection six times per week (0.30 mg/kg.wk)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (C), no GH treatment
Number of subjects: 154
Study: 11840368

Group type: EXPERIMENTAL
Intervention: Simvastatin (5 mg/day, increased to maximum 20 mg/day if non-HDL > 135 mg/dL)
Number of subjects: 57
Study: 9803724

Group type: EXPERIMENTAL
Intervention: Counseling by trained physicians-in-training (residents)
Number of subjects: 1086

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1086
Study: 7699682

Group type: EXPERIMENTAL
Intervention: Topical minoxidil 5% solution
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2618585

Group type: EXPERIMENTAL
Intervention: Nonathymulin (NT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 363750

Group type: EXPERIMENTAL
Intervention: Povidone iodine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Buffered peroxyborate
Number of subjects: 20
Study: 30944142

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine-alcohol for skin preparation before catheter insertion
Number of subjects: 1000

Group type: COMPARATOR
Intervention: 5% povidone iodine-alcohol for skin preparation before catheter insertion
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Use of new technologies (catheters designed to minimise blood exposure, zero-reflux needleless connectors, disinfecting caps, flushing PVCs)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard care without new technologies
Number of subjects: 1000
Study: 28683216

Group type: EXPERIMENTAL
Intervention: Inspi-Neb
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conti-Neb
Number of subjects: 6
Study: 27007578

Group type: EXPERIMENTAL
Intervention: PET-CT-guided surveillance
Number of subjects: 564

Group type: COMPARATOR
Intervention: Planned neck dissection
Number of subjects: 564
Study: 24243886

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg/d
Number of subjects: 9612

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9612
Study: 22502942

Group type: EXPERIMENTAL
Intervention: ADT plus external-beam radiotherapy
Number of subjects: 264

Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 264
Study: 19929371

Group type: EXPERIMENTAL
Intervention: Treatment for CDI
Number of subjects: 52
Study: 17927556

Group type: EXPERIMENTAL
Intervention: Risk reduction counseling that included information, motivational enhancement and behavior skills building
Number of subjects: 319

Group type: COMPARATOR
Intervention: Brief HIV education counseling
Number of subjects: 319
Study: 15991169

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 40
Study: 12024434

Group type: EXPERIMENTAL
Intervention: Group C meningococcal conjugate vaccine
Number of subjects: 182
Study: 9675657

Group type: EXPERIMENTAL
Intervention: Interferon treatment with N-acetyl-cysteine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Interferon treatment without N-acetyl-cysteine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 25
Study: 8016036

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg), chewed ad libitum
Number of subjects: 173

Group type: COMPARATOR
Intervention: No nicotine gum
Number of subjects: 173
Study: 2605867

Group type: EXPERIMENTAL
Intervention: Triple-hormone combination (adrenaline, cortisol, glucagon)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 32
Study: 7918261

Group type: EXPERIMENTAL
Intervention: FASTPAC
Number of subjects: 44
Study: 362568

Group type: EXPERIMENTAL
Intervention: Betamethasone 17‐valerate 0.1%
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.05%
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.25%
Number of subjects: 15
Study: 31400516

Group type: EXPERIMENTAL
Intervention: ROC (Regulation of Cues) program
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: ROC combined with BWL
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: BWL alone
Number of subjects: 271

Group type: COMPARATOR
Intervention: Active comparator
Number of subjects: 271
Study: 28031318

Group type: EXPERIMENTAL
Intervention: Health checks (up to three checks from 1982 to 1994)
Number of subjects: 17845

Group type: COMPARATOR
Intervention: Control group (no health checks)
Number of subjects: 17845
Study: 27986736

Group type: EXPERIMENTAL
Intervention: Wuling San
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 25084831

Group type: EXPERIMENTAL
Intervention: Sepsis-derived interphase neutrophils
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Depletion or inhibition of interphase neutrophils in vitro
Number of subjects: 35

Group type: COMPARATOR
Intervention: Interphase neutrophils in septic shock
Number of subjects: 35
Study: 22880820

Group type: EXPERIMENTAL
Intervention: Thalidomide 100 mg once a day for 14 days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 31
Study: 19083096

Group type: EXPERIMENTAL
Intervention: Partition-herb moxibustion
Number of subjects: 109

Group type: COMPARATOR
Intervention: Partition-bran moxibustion
Number of subjects: 109
Study: 17346297

Group type: EXPERIMENTAL
Intervention: Dermasilk fabric (sericin-free silk treated with AEGIS AEM5772/5)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cotton fabric
Number of subjects: 22
Study: 15117904

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 34
Study: 11181305

Group type: EXPERIMENTAL
Intervention: eptifibatide
Number of subjects: 100

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 100
Study: 10328185

Group type: EXPERIMENTAL
Intervention: Centrifugal pump
Number of subjects: 60

Group type: COMPARATOR
Intervention: Roller pump
Number of subjects: 60
Study: 8083708

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy and surgical resection
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Resection of pulmonary metastases
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with > or = 90% necrosis and postoperative chemotherapy
Number of subjects: 111

Group type: COMPARATOR
Intervention: Tumor-containing resection margin
Number of subjects: 111

Group type: COMPARATOR
Intervention: Poor response to preoperative chemotherapy and/or lack of postoperative chemotherapy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Three or fewer pulmonary nodules
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Four or fewer recurrent pulmonary nodules
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Unilateral pulmonary metastases
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Longer intervals between primary tumor resection and metastases
Number of subjects: 111
Study: 2572182

Group type: EXPERIMENTAL
Intervention: Loratadine 0.11-0.24 mg/kg once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dexchlorpheniramine 0.10-0.23 mg/kg every 8 hours
Number of subjects: 40
Study: 803831

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition with hyperosmolar glucose (10.5 gm nitrogen, 2,340 kilocalories/day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition with hyperosmolar glucose (5.9 gm nitrogen, 1,600 kilocalories/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no nitrogen, 520 kilocalories/day)
Number of subjects: 15
Study: 31657262

Group type: EXPERIMENTAL
Intervention: Group-based, individualized physiotherapy intervention (6-week duration)
Number of subjects: 13
Study: 30361241

Group type: EXPERIMENTAL
Intervention: 8-week once-weekly regimen of rifapentine plus isoniazid
Number of subjects: 1284
Study: 27473688

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for cannabis cessation (1-hour sessions once a week for 16 weeks, in addition to pharmacological treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (psychoeducation + pharmacological treatment)
Number of subjects: 0
Study: 25458786

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (4g/day for 4 weeks)
Number of subjects: 10
Study: 22828598

Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 51

Group type: COMPARATOR
Intervention: Centrifugation
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Cell salvage
Number of subjects: 51
Study: 20435262

Group type: EXPERIMENTAL
Intervention: Bypass surgery (BSX)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Balloon angioplasty (BAP)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Baseline factors
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Weibull predictive model
Number of subjects: 452
Study: 18319309

Group type: EXPERIMENTAL
Intervention: Estradiol (E2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: E2 plus Medroxyprogesterone acetate (MPA)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 15939408

Group type: EXPERIMENTAL
Intervention: Testosterone (0.5 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 12902802

Group type: EXPERIMENTAL
Intervention: Monotherapy postpartum
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Combination therapy postpartum
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy postpartum
Number of subjects: 497

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) therapy
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Stable therapy
Number of subjects: 497
Study: 11082141

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 8785

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 8785
Study: 8781906

Group type: EXPERIMENTAL
Intervention: Clinical diagnosis in dyspeptic patients (open-access endoscopy group)
Number of subjects: 1233

Group type: COMPARATOR
Intervention: Clinical diagnosis in dyspeptic patients (empirically managed group)
Number of subjects: 1233

Group type: EXPERIMENTAL
Intervention: Non-ulcer dyspepsia (both groups)
Number of subjects: 1233

Group type: EXPERIMENTAL
Intervention: Clinical prediction of ulcer (open-access endoscopy group)
Number of subjects: 1233

Group type: COMPARATOR
Intervention: Clinical prediction of ulcer (empirically managed group)
Number of subjects: 1233

Group type: EXPERIMENTAL
Intervention: Misclassification of major pathologic lesions as non-ulcer dyspepsia (both groups)
Number of subjects: 1233

Group type: EXPERIMENTAL
Intervention: Patients' provisional diagnoses
Number of subjects: 1233
Study: 1516491

Group type: EXPERIMENTAL
Intervention: Beef insulin (B)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sulfated beef insulin (SB)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Pork insulin (P)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Human insulin (H)
Number of subjects: 26
Study: 2981652

Group type: EXPERIMENTAL
Intervention: Metkephamid (50 mg intramuscularly)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31502872

Group type: EXPERIMENTAL
Intervention: Stress and Anger Management Program (STAMP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 23
Study: 27043047

Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 523

Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 523
Study: 24881210

Group type: EXPERIMENTAL
Intervention: Stage II surgery of dental implantation
Number of subjects: 29
Study: 22248495

Group type: EXPERIMENTAL
Intervention: FAST
Number of subjects: 19

Group type: COMPARATOR
Intervention: FED
Number of subjects: 19
Study: 20375736

Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Waitlist (WL) control group
Number of subjects: 28
Study: 18535684

Group type: EXPERIMENTAL
Intervention: Prestige ST cervical disc prosthesis (Medtronic Sofamor Danek)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 19
Study: 16027567

Group type: EXPERIMENTAL
Intervention: Inpatient counseling with telephone follow-up
Number of subjects: 168

Group type: COMPARATOR
Intervention: Inpatient counseling
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study: 11818704

Group type: EXPERIMENTAL
Intervention: Oral calcitriol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: IV calcitriol
Number of subjects: 28
Study: 10353012

Group type: EXPERIMENTAL
Intervention: Sphincteroclasy
Number of subjects: 52
Study: 7860754

Group type: EXPERIMENTAL
Intervention: CD4 binding site antibodies
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Low viral load (defined by two or more negative HIV-1 viral cultures during pregnancy)
Number of subjects: 47
Study: 2017111

Group type: EXPERIMENTAL
Intervention: Hydergine/Nifedipine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 50
Study: 6127095

Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI2) 0-6 ng kg-1 min-1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI2) 1 and 2 ng/ml
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Atropine 0.04 mg/kg i.v.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Atenolol 0.2 mg/kg i.v.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Propranolol 0.2 mg/kg i.v.
Number of subjects: 6
Study: 31973713

Group type: EXPERIMENTAL
Intervention: Point OutWords intervention (half an hour, five times a week, for 8 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (equal caregiver-led contact time with iPad using control apps)
Number of subjects: 46
Study: 31287230

Group type: EXPERIMENTAL
Intervention: Upadacitinib (15 mg once daily)
Number of subjects: 1629

Group type: COMPARATOR
Intervention: Adalimumab (40 mg every other week)
Number of subjects: 1629

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1629
Study: 29228946

Group type: EXPERIMENTAL
Intervention: School-based intervention
Number of subjects: 1430
Study: 26622083

Group type: EXPERIMENTAL
Intervention: Programmed physical activities for 28 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no programmed physical activities)
Number of subjects: 100
Study: 24840774

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate skin sealant
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard measures for preventing contamination
Number of subjects: 50
Study: 22814692

Group type: EXPERIMENTAL
Intervention: Brushing without dentifrice
Number of subjects: 24

Group type: COMPARATOR
Intervention: Brushing with dentifrice
Number of subjects: 24
Study: 19803612

Group type: EXPERIMENTAL
Intervention: Children and adolescents' perceptions of self-blame and use of secondary control coping (acceptance, distraction, cognitive restructuring, positive thinking)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Higher levels of current depressive symptoms in parents
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Interparental conflict
Number of subjects: 108
Study: 17719366

Group type: EXPERIMENTAL
Intervention: MPC (medical investigations + psychological counselling)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: MC (medical investigations + no psychological counselling)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control (no specific postmiscarriage counselling)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: MC and MPC groups (with identified cause of miscarriage)
Number of subjects: 127